Skip to main content
Watch Insiders

Corporate insider profile

Noah Goodman Insider Trades

Latest reported as Chief Business Officer of Kymera Therapeutics, Inc. (KYMR).

Purchase filings
0
Reported companies
1
Net open-market value
-$1,326,058.81
Latest transaction
Jul 1, 2026

Affiliated corporations

Reported company relationships

KYMRLatest reported

Kymera Therapeutics, Inc.

Chief Business Officer

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Jul 1, 2026Kymera Therapeutics, Inc. (KYMR)Chief Business OfficerSale3,389$114.29$387,329
Jun 25, 2026Kymera Therapeutics, Inc. (KYMR)Chief Business OfficerSale5,000$114.00$570,000
Jun 22, 2026Kymera Therapeutics, Inc. (KYMR)Chief Business OfficerSale2,500$99.00$247,500
Apr 14, 2026Kymera Therapeutics, Inc. (KYMR)Chief Business OfficerSale1,347$90.00$121,230